These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19520090)

  • 21. Depletion of Mac1-positive macrophages protects DBA/2 mice from encephalomyocarditis virus-induced myocarditis and diabetes.
    Hirasawa K; Tsutsui S; Takeda M; Mizutani M; Itagaki S; Doi K
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():737-41. PubMed ID: 8627262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevance of inflammatory cell infiltrates for complete atrioventricular block in experimental murine myocarditis.
    Kishimoto C; Ohmae M; Tomioka N
    Cardiovasc Pathol; 2006; 15(3):139-43. PubMed ID: 16697926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of encephalomyocarditis experimental infection in young piglets: a potential animal model to study viral myocarditis.
    Gelmetti D; Meroni A; Brocchi E; Koenen F; Cammarata G
    Vet Res; 2006; 37(1):15-23. PubMed ID: 16336922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.
    Matsui S; Matsumori A; Matoba Y; Uchida A; Sasayama S
    J Clin Invest; 1994 Sep; 94(3):1212-7. PubMed ID: 8083362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of myocardial damage and alteration of lymphocyte subsets in murine model of postpartum myocarditis.
    Yokoyama T; Kanda T; Suzuki T; Murata K
    Am J Cardiovasc Pathol; 1993; 4(4):343-51. PubMed ID: 8305197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart.
    Nishio R; Matsumori A; Shioi T; Wang W; Yamada T; Ono K; Sasayama S
    J Am Coll Cardiol; 1998 Sep; 32(3):808-15. PubMed ID: 9741531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of viral myocarditis in mice by interleukin-6.
    Kanda T; McManus JE; Nagai R; Imai S; Suzuki T; Yang D; McManus BM; Kobayashi I
    Circ Res; 1996 May; 78(5):848-56. PubMed ID: 8620605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encephalomyocarditis (EMC) virus-induced sialodacryoadenitis in mice.
    Ohguchi A; Nakayama Y; Doi C; Nakayama H; Doi K
    Exp Mol Pathol; 2005 Feb; 78(1):58-63. PubMed ID: 15596062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats.
    Palaniyandi SS; Watanabe K; Ma M; Tachikawa H; Kodama M; Aizawa Y
    Eur J Immunol; 2004 Dec; 34(12):3508-15. PubMed ID: 15549732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis.
    Lee JK; Zaidi SH; Liu P; Dawood F; Cheah AY; Wen WH; Saiki Y; Rabinovitch M
    Nat Med; 1998 Dec; 4(12):1383-91. PubMed ID: 9846575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental encephalomyocarditis virus infection in small laboratory rodents.
    Doi K
    J Comp Pathol; 2011 Jan; 144(1):25-40. PubMed ID: 20594559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity.
    Matsumori A; Igata H; Ono K; Iwasaki A; Miyamoto T; Nishio R; Sasayama S
    Jpn Circ J; 1999 Dec; 63(12):934-40. PubMed ID: 10614837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus.
    Yamada T; Matsumori A; Sasayama S
    Circulation; 1994 Feb; 89(2):846-51. PubMed ID: 8313574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice.
    Yamamoto K; Shioi T; Uchiyama K; Miyamoto T; Sasayama S; Matsumori A
    J Am Coll Cardiol; 2003 Dec; 42(11):2000-6. PubMed ID: 14662266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression.
    Saegusa S; Fei Y; Takahashi T; Sumino H; Moriya J; Kawaura K; Yamakawa J; Itoh T; Morimoto S; Nakahashi T; Iwai K; Matsumoto M; Kanda T
    Cardiovasc Drugs Ther; 2007 Jun; 21(3):155-60. PubMed ID: 17484035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat stress aggravates viral myocarditis in mice.
    Kanda T; Nakano M; Yokoyama T; Hoshino Y; Okajima F; Tanaka T; Saito Y; Nagai R; Kobayashi I
    Life Sci; 1999; 64(2):93-101. PubMed ID: 10069487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of substance P in viral myocarditis in mice.
    Wang Y; Shimada M; Xu Y; Hu D; Nishio R; Matsumori A
    Heart Vessels; 2010 Jul; 25(4):348-52. PubMed ID: 20676845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of bosentan, an endothelin receptor antagonist.
    Ono K; Matsumori A; Shioi T; Furukawa Y; Sasayama S
    Circulation; 1999 Oct; 100(17):1823-9. PubMed ID: 10534471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of experimental viral myocarditis with interleukin-10.
    Nishio R; Matsumori A; Shioi T; Ishida H; Sasayama S
    Circulation; 1999 Sep; 100(10):1102-8. PubMed ID: 10477536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.